OR WAIT null SECS
May 20, 2019
Catalent expands gene therapy capabilities with $1.2-billion acquisition of Paragon Bioservices.
May 17, 2019
The company announced plans to construct a 1.3 million-ft2 integrated manufacturing center in Chengdu, China.
April 18, 2019
The expansion of the CDMO’s Skokie, IL facility includes additional refrigeration and freezer space.
The company passed a seven-day FDA surveillance GMP inspection and announced two upcoming manufacturing partnerships.
April 05, 2019
The companies form a strategic joint venture for developing and manufacturing live biotherapeutics.
April 03, 2019
Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.
April 02, 2019
Moving from paper-based to digitalized processes is the first step to enabling quality management and manufacturing to work in sync.
March 26, 2019
Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium.
March 20, 2019
Think ahead to production requirements when planning strategies in early development of gene and cell therapies.
The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.